Generated by GPT-5-mini| Diversity Alliance for Science | |
|---|---|
| Name | Diversity Alliance for Science |
| Formation | 2016 |
| Type | Nonprofit advocacy organization |
| Location | United States |
| Leader title | Executive Director |
| Leader name | Dr. Maria Santos |
Diversity Alliance for Science is a nonprofit organization advocating for inclusive participation in biomedical research, pharmaceutical development, and allied health professions. Founded to address underrepresentation in clinical trials, workforce pipelines, and research leadership, the group engages with academic centers, regulatory bodies, and community partners to expand access and equity in translational science. The Alliance operates programs that connect stakeholders across universities, industry, and philanthropy to promote diversification of clinical research cohorts and research leadership.
The organization was established in 2016 amid debates over diversity in clinical research involving Food and Drug Administration, National Institutes of Health, Centers for Disease Control and Prevention, and academic medical centers such as Johns Hopkins University and Mayo Clinic. Early activities intersected with initiatives from American Association for the Advancement of Science, National Academy of Medicine, American Medical Association, and advocacy groups like NAACP and National Urban League to respond to historical exclusions highlighted by studies from Harvard University and University of California, San Francisco. Leadership meetings included representatives from Pfizer, Johnson & Johnson, Merck & Co., and biopharmaceutical consortia such as PhRMA. The Alliance’s formation paralleled policy discussions at the U.S. Congress and collaborations with regulatory science programs at Duke University and Stanford University School of Medicine.
The stated mission aligns with recommendations from the Institute of Medicine and directives from the Office for Human Research Protections to increase representation in trials overseen by ClinicalTrials.gov and regulators such as the European Medicines Agency. Objectives include improving recruitment practices at sites affiliated with University of Pennsylvania Health System, Massachusetts General Hospital, and Cedars-Sinai Medical Center; enhancing data standards compatible with initiatives by World Health Organization and Global Alliance for Genomics and Health; and fostering career pathways modeled on programs from Howard University, Spelman College, and Morehouse School of Medicine. The Alliance emphasizes measurable outcomes consistent with guidance from Bill & Melinda Gates Foundation and evaluation frameworks used by Robert Wood Johnson Foundation.
Programs span workforce development, trial diversity recruitment, and community engagement, often partnering with entities such as American Association of Medical Colleges, Society for Clinical Research Sites, and Association of Clinical Research Professionals. Workforce programs mirror training efforts at Columbia University Medical Center and University of Chicago Medicine while using mentorship models seen at National Science Foundation and National Institutes of Health diversity supplements. Trial recruitment initiatives coordinate with hospital networks including Kaiser Permanente and research hubs like Beth Israel Deaconess Medical Center to implement outreach practices from Community-Campus Partnerships for Health and the Patient-Centered Outcomes Research Institute. Public education draws on methods used by Smithsonian Institution and Centers for Medicare & Medicaid Services communications campaigns.
Membership comprises representatives from universities such as Yale School of Medicine, University of Michigan Medical School, and UCLA Health; biopharma firms including AstraZeneca and Novartis; foundations like Wellcome Trust; and civil society groups including March of Dimes and Alzheimer's Association. Governance follows nonprofit standards used by Independent Sector and board practices at institutions such as Rockefeller Foundation and Johns Hopkins Bloomberg School of Public Health. Committees include an executive board, scientific advisory panel with experts from National Cancer Institute and Centers for Disease Control and Prevention, and community advisory boards reflecting constituencies from Urban League of Greater Atlanta and patient advocacy groups like American Heart Association.
The Alliance collaborates with clinical research networks such as All of Us Research Program and consortia like Global Alliance for Genomics and Health; leverages data standards promoted by Observational Health Data Sciences and Informatics and CDISC; and participates in policy dialogues with Office of Minority Health and the U.S. Department of Health and Human Services. It has convened symposia with academic partners including University of North Carolina at Chapel Hill, University of Texas Southwestern Medical Center, and Emory University and coordinated pilot projects with industry partners such as Bristol-Myers Squibb and contract research organizations like IQVIA. International collaborations have involved World Health Organization, European Commission, and NGOs like Médecins Sans Frontières.
Evaluation uses metrics consistent with frameworks from National Academy of Sciences, RAND Corporation, and funders such as Gates Foundation and Robert Wood Johnson Foundation. Reported impacts include increased enrollment diversity in trials at partnering sites like University of Miami Health System and improved career advancement for researchers from historically Black colleges such as Howard University and Florida A&M University. Independent assessments by think tanks including Kaiser Family Foundation and Brookings Institution have cited the Alliance’s role in convening stakeholders and piloting recruitment best practices. Ongoing evaluation leverages data from ClinicalTrials.gov, electronic health record initiatives at Epic Systems Corporation, and population health studies conducted by Johns Hopkins University.
Category:Non-profit organizations based in the United States